Goldman Sachs Group Inc Iridex Corp Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Iridex Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 47,793 shares of IRIX stock, worth $46,837. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,793Holding current value
$46,837% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IRIX
# of Institutions
22Shares Held
2.84MCall Options Held
0Put Options Held
0-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$980,0002.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA579KShares$567,1360.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny389KShares$381,2780.0% of portfolio
-
Amh Equity LTD184KShares$180,5450.3% of portfolio
-
Geode Capital Management, LLC Boston, MA133KShares$130,3970.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $15.7M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...